In an interview with the newspaper Die Welt, HanseMerkur CEO Eberhard Sautter says of the PanTum Detect®: "The test contained in our 'Krebs-Scan' has therefore closed a gap."
The Shield test from US company Guardant Health is the first blood test for the early detection of cancer to receive important FDA approval in the USA. Shield has been approved as a primary screening option for colorectal cancer.